Print

Orchid Chemicals & Pharmaceuticals Ltd
Unaudited Consolidated Financial Results for the Quarter/Nine months ended December 31, 2010
(Rs.Lakhs)
Sl No
Particulars
Three months ended
31-Dec-10
Three months ended
31-Dec-09
Nine months ended
31-Dec-10
Nine months ended
31-Dec-09
1
 Sales
46,246.47
33,674.95
118,913.00
99,353.96
2
 Other Operating Income
1,610.81
2,370.01
5,646.91
3,580.44
3
 Total Operating Income (1+2)
47,857.28
36,044.96
124,559.91
102,934.39
4
Expenditure
a) Decrease/(Increase) in Stock in trade
(5,023.71)
(45.44)
(12,479.39)
(730.38)
b) Material Cost
26,144.83
12,734.23
67,556.49
37,032.87
c) Purchase of Traded Goods
1,275.68
617.00
3,450.09
2,599.70
d) Staff Cost
4,054.66
3,386.16
11,262.69
9,795.99
e) Depreciation / Amortisation
3,223.92
3,917.93
9,765.01
11,680.30
f) Other Expenditure
8,698.01
12,143.90
26,100.85
31,117.76
g) Total
38,373.39
32,753.78
105,655.73
91,496.24
5
Profit from Operations before Other Income, Interest & Exceptional Item (3-4)
9,483.89
3,291.18
18,904.18
11,438.16
6
Other Income
2.99
-
267.10
-
7
Profit before Interest & Exceptional Item (5+6)
9,486.88
3,291.18
19,171.28
11,438.16
8
 Interest and Finance Charges
2,710.51
5,384.69
7,537.47
16,273.77
9
 Profit from ordinary activities before Exceptional Item (7-8)
6,776.37
(2,093.51)
11,633.81
(4,835.61)
10
 Exceptional Item - Exchange gain on FCCBs
784.26
381.28
696.61
(442.67)
11
 Profit before Tax after Exceptional Item
7,560.63
(1,712.23)
12,330.42
(5,278.27)
12
 Tax expenses
1,898.31
179.39
2,581.93
547.51
13
 Profit after Tax
5,662.32
(1,891.62)
9,748.48
(5,825.78)
14
Earning per Share (EPS) Basic Rs.
8.04
(2.69)
13.84
(8.27)
15
Earnings per share (EPS) Diluted Rs.
6.64
(2.69)
11.44
(8.27)
16
 Aggregate of Public Shareholding
- Number of Equity shares
48939460
55529904
48939460
55529904
- Percentage of Shareholding
69.48
78.83
69.48
78.83
17
Promoters and Promoter group Shareholding
 
 
a. Pledged / Encumbered
- Number of Shares
17653683
7847883
17653683
7847883
 
- Percentage of Shares (as a % of the total shareholding of promoter and promoter group)
82.10
52.63
82.10
52.63
 
- Percentage of Shares (as a % of the total share captial of company)
25.06
11.14
25.06
11.14
b. Non Encumbered
    
 
 

- Number of shares
3848933
7064289
3848933
7064289
  - Percentage of shares (as a % the total shareholding of promoter and promoter group)
17.90
47.37
17.90
47.37
- Percentage of shares (as a % of the total share capital of company)
5.46
10.03
5.46
10.03

* EPS is for the period (not annualised)
  • The Company is operating in single segment (i.e)"Pharmaceuticals".
  • The Company has exercised the option provided under the Companies (Accounting Standards) Amendment Rules, 2006 dated 31st March, 2009 in respect of AS 11. The amount remaining to be amortised in the financial statements as on December 31, 2010 on account of exercising the above option is Rs.1159.22 lakhs (previous period Rs. 443.75 lakhs).
  • Foreign Currency Convertible Bonds due in November 2010, aggregating to USD 25.69 million (Rs.114.10 crore) were redeemed by the Company on November 03, 2010.
  • Exceptional items represents exchange gain / (loss) on FCCBs.
  • The Company received 52 complaints during the quarter ended 31st December, 2010 from the shareholders and no complaints were pending as on 31st December, 2010.
  • Previous period figures have been regrouped wherever necessary.

Place : Mumbai
Date : January 19, 2011

For and on behalf of the Board

K.Raghavendra Rao
Chairman & Managing Director